These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1543834

  • 21. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990.
    Venesmaa P.
    Obstet Gynecol; 1994 Jul; 84(1):8-11. PubMed ID: 8008329
    [Abstract] [Full Text] [Related]

  • 22. Questioning current policies for the curative management of ovarian carcinoma.
    Fuks Z.
    Isr J Med Sci; 1988 Jul; 24(9-10):572-9. PubMed ID: 3060447
    [Abstract] [Full Text] [Related]

  • 23. [Importance of the combined therapy for the adequate treatment of malignant epithelial tumors of the ovary].
    Pescetto G.
    Minerva Ginecol; 1984 Apr; 36(4):185-9. PubMed ID: 6462521
    [No Abstract] [Full Text] [Related]

  • 24. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E, Deavers MT, Silva EG, Malpica A.
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [Abstract] [Full Text] [Related]

  • 25. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S, EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm.
    J Natl Cancer Inst; 2003 Jan 15; 95(2):113-25. PubMed ID: 12529344
    [Abstract] [Full Text] [Related]

  • 26. Management of epithelial ovarian tumors of low malignant potential.
    Trimble CL, Trimble EL.
    Gynecol Oncol; 1994 Dec 15; 55(3 Pt 2):S52-61. PubMed ID: 7835812
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of the role of second-look surgery in ovarian cancer.
    Chambers SK, Chambers JT, Kohorn EI, Lawrence R, Schwartz PE.
    Obstet Gynecol; 1988 Sep 15; 72(3 Pt 1):404-8. PubMed ID: 3405557
    [Abstract] [Full Text] [Related]

  • 28. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A, Iacconi P, Fanucchi A, Cosio S, Teti G, Genazzani AR.
    Anticancer Res; 2000 Sep 15; 20(3B):1959-64. PubMed ID: 10928134
    [Abstract] [Full Text] [Related]

  • 29. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME, Mink PJ, Curtis R, Cote TR, Brooks S, Hartge P, Devesa S.
    Cancer; 2004 Mar 01; 100(5):1045-52. PubMed ID: 14983501
    [Abstract] [Full Text] [Related]

  • 30. Immunophenotype of ovarian cancer as predictor of clinical outcome: evaluation at primary surgery and second-look procedure.
    Goff BA, Ries JA, Els LP, Coltrera MD, Gown AM.
    Gynecol Oncol; 1998 Sep 01; 70(3):378-85. PubMed ID: 9790791
    [Abstract] [Full Text] [Related]

  • 31. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
    Friedman RL, Eisenkop SM, Wang HJ.
    Gynecol Oncol; 1997 Oct 01; 67(1):88-94. PubMed ID: 9345362
    [Abstract] [Full Text] [Related]

  • 32. [Prognosis factors in epithelial tumors of the ovary].
    Frigerio L, Ferrari A, Busci L, Pirondini A, Garsia S, Caldarella M, Pifarotti G.
    Ann Ostet Ginecol Med Perinat; 1989 Oct 01; 110(6):283-9. PubMed ID: 2639615
    [Abstract] [Full Text] [Related]

  • 33. An assessment of pathologic features and treatment modalities in ovarian tumors of low malignant potential.
    Hopkins MP, Kumar NB, Morley GW.
    Obstet Gynecol; 1987 Dec 01; 70(6):923-9. PubMed ID: 3684131
    [Abstract] [Full Text] [Related]

  • 34. [Treatment of ovarian cancer].
    Cianti C.
    Clin Ter; 2002 Dec 01; 153(2):135-44. PubMed ID: 12078339
    [Abstract] [Full Text] [Related]

  • 35. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T, Adolph A, Krepart GV, Lotocki R, Heywood MS.
    Gynecol Oncol; 2002 May 01; 85(2):351-5. PubMed ID: 11972399
    [Abstract] [Full Text] [Related]

  • 36. Epithelial ovarian tumors of low malignant potential.
    Massad LS, Hunter VJ, Szpak CA, Clarke-Pearson DL, Creasman WT.
    Obstet Gynecol; 1991 Dec 01; 78(6):1027-32. PubMed ID: 1945202
    [Abstract] [Full Text] [Related]

  • 37. Management of early-stage ovarian cancer.
    Schilder RJ, Young RC.
    Hematol Oncol Clin North Am; 1992 Aug 01; 6(4):867-77. PubMed ID: 1500390
    [Abstract] [Full Text] [Related]

  • 38. Management of borderline tumors of the ovary: state of the art.
    Tropé C, Kaern J.
    Semin Oncol; 1998 Jun 01; 25(3):372-80. PubMed ID: 9633850
    [Abstract] [Full Text] [Related]

  • 39. Ovarian cancer of epithelial origin--an update.
    Menczer J.
    Isr J Med Sci; 1993 Aug 01; 29(8):477-83. PubMed ID: 8407278
    [No Abstract] [Full Text] [Related]

  • 40. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM, Eisenkop SM, Schlaerth JB, Ballon SC.
    Am J Obstet Gynecol; 2000 Jun 01; 182(6):1321-7. PubMed ID: 10871445
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.